APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-vertigo Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-vertigo Drugs Industry Growth and Trends Forecast to 2032

27 December 2025124 pages

Choose your research edition.

Industry ResearchAnti-vertigo Drugs Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-vertigo Drugs Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Anti-vertigo Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-vertigo Drugs Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-vertigo Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Anti-vertigo Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-vertigo Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-vertigo Drugs include Zhejiang Proconyu Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Weifang Zhongshi Pharmaceutical Co., Ltd., Tianfang Pharmaceutical Co., Ltd., Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Shandong Xinyi Pharmaceutical Co., Ltd., Renhetang Pharmaceutical Co., Ltd. and Jiangsu Sihuan Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-vertigo Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-vertigo Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-vertigo Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-vertigo Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-vertigo Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-vertigo Drugs Market by Company

Zhejiang Proconyu Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Weifang Zhongshi Pharmaceutical Co., Ltd.

Tianfang Pharmaceutical Co., Ltd.

Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Shandong Xinyi Pharmaceutical Co., Ltd.

Renhetang Pharmaceutical Co., Ltd.

Jiangsu Sihuan Biopharmaceutical Co., Ltd.

Jinan Yongning Pharmaceutical Co., Ltd.

China Resources Shuanghe Pharmaceutical Co., Ltd.

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.

Heilongjiang Yidahong Pharmaceutical Co., Ltd.

Henan Zhongjie Pharmaceutical Co., Ltd.

Guangdong Lingnan Pharmaceutical Co., Ltd.

Guangdong Bangmin Pharmaceutical Co., Ltd.

Beijing Juneng Pharmaceutical Co., Ltd.

Wellona Pharma

SAVAL Pharma

Santa Cruz Biotechnology, Inc

Kent Pharmaceuticals Ltd

Kabir Lifesciences

AdvaCare Pharma

Anti-vertigo Drugs Segment by Type

Betahistine

Diphenidol

Flunarizine

Anti-vertigo Drugs Segment by Application

Clinic

Hospital

Pharmacy

Other

Anti-vertigo Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-vertigo Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-vertigo Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-vertigo Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-vertigo Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-vertigo Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Betahistine Table 2. Major Company of Diphenidol Table 3. Major Company of Flunarizine Table 4. Global Anti-vertigo Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Anti-vertigo Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Anti-vertigo Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Anti-vertigo Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Anti-vertigo Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Anti-vertigo Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Anti-vertigo Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Anti-vertigo Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Anti-vertigo Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Anti-vertigo Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Anti-vertigo Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Anti-vertigo Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Anti-vertigo Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Anti-vertigo Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Anti-vertigo Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Anti-vertigo Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Anti-vertigo Drugs Industry Trends Table 26. Anti-vertigo Drugs Industry Drivers Table 27. Anti-vertigo Drugs Industry Opportunities and Challenges Table 28. Anti-vertigo Drugs Industry Restraints Table 29. Global Anti-vertigo Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Anti-vertigo Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Anti-vertigo Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Anti-vertigo Drugs Sales Share by Company (2021-2026) Table 33. Global Anti-vertigo Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Anti-vertigo Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Anti-vertigo Drugs Major Company Production Sites and Headquarters Table 36. Global Anti-vertigo Drugs Company, Product Type & Application Table 37. Global Anti-vertigo Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Anti-vertigo Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Anti-vertigo Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Anti-vertigo Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Anti-vertigo Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Anti-vertigo Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Anti-vertigo Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Anti-vertigo Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Anti-vertigo Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Anti-vertigo Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Anti-vertigo Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Anti-vertigo Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Anti-vertigo Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Anti-vertigo Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Anti-vertigo Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Anti-vertigo Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Anti-vertigo Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Anti-vertigo Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Anti-vertigo Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Anti-vertigo Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Anti-vertigo Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Anti-vertigo Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Anti-vertigo Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Anti-vertigo Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Anti-vertigo Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Anti-vertigo Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Anti-vertigo Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Anti-vertigo Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Anti-vertigo Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Zhejiang Proconyu Pharmaceutical Co., Ltd. Company Information Table 73. Zhejiang Proconyu Pharmaceutical Co., Ltd. Business Overview Table 74. Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 76. Zhejiang Proconyu Pharmaceutical Co., Ltd. Recent Development Table 77. Southwest Pharmaceutical Co., Ltd. Company Information Table 78. Southwest Pharmaceutical Co., Ltd. Business Overview Table 79. Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 81. Southwest Pharmaceutical Co., Ltd. Recent Development Table 82. Weifang Zhongshi Pharmaceutical Co., Ltd. Company Information Table 83. Weifang Zhongshi Pharmaceutical Co., Ltd. Business Overview Table 84. Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 86. Weifang Zhongshi Pharmaceutical Co., Ltd. Recent Development Table 87. Tianfang Pharmaceutical Co., Ltd. Company Information Table 88. Tianfang Pharmaceutical Co., Ltd. Business Overview Table 89. Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 91. Tianfang Pharmaceutical Co., Ltd. Recent Development Table 92. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Company Information Table 93. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Business Overview Table 94. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 96. Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Development Table 97. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 98. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 99. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 101. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 102. Shandong Xinyi Pharmaceutical Co., Ltd. Company Information Table 103. Shandong Xinyi Pharmaceutical Co., Ltd. Business Overview Table 104. Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 106. Shandong Xinyi Pharmaceutical Co., Ltd. Recent Development Table 107. Renhetang Pharmaceutical Co., Ltd. Company Information Table 108. Renhetang Pharmaceutical Co., Ltd. Business Overview Table 109. Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 111. Renhetang Pharmaceutical Co., Ltd. Recent Development Table 112. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Company Information Table 113. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Business Overview Table 114. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 116. Jiangsu Sihuan Biopharmaceutical Co., Ltd. Recent Development Table 117. Jinan Yongning Pharmaceutical Co., Ltd. Company Information Table 118. Jinan Yongning Pharmaceutical Co., Ltd. Business Overview Table 119. Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 121. Jinan Yongning Pharmaceutical Co., Ltd. Recent Development Table 122. China Resources Shuanghe Pharmaceutical Co., Ltd. Company Information Table 123. China Resources Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 124. China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 126. China Resources Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 127. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information Table 128. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview Table 129. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 131. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Development Table 132. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Company Information Table 133. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Business Overview Table 134. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 136. Heilongjiang Yidahong Pharmaceutical Co., Ltd. Recent Development Table 137. Henan Zhongjie Pharmaceutical Co., Ltd. Company Information Table 138. Henan Zhongjie Pharmaceutical Co., Ltd. Business Overview Table 139. Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 141. Henan Zhongjie Pharmaceutical Co., Ltd. Recent Development Table 142. Guangdong Lingnan Pharmaceutical Co., Ltd. Company Information Table 143. Guangdong Lingnan Pharmaceutical Co., Ltd. Business Overview Table 144. Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 146. Guangdong Lingnan Pharmaceutical Co., Ltd. Recent Development Table 147. Guangdong Bangmin Pharmaceutical Co., Ltd. Company Information Table 148. Guangdong Bangmin Pharmaceutical Co., Ltd. Business Overview Table 149. Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 151. Guangdong Bangmin Pharmaceutical Co., Ltd. Recent Development Table 152. Beijing Juneng Pharmaceutical Co., Ltd. Company Information Table 153. Beijing Juneng Pharmaceutical Co., Ltd. Business Overview Table 154. Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio Table 156. Beijing Juneng Pharmaceutical Co., Ltd. Recent Development Table 157. Wellona Pharma Company Information Table 158. Wellona Pharma Business Overview Table 159. Wellona Pharma Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Wellona Pharma Anti-vertigo Drugs Product Portfolio Table 161. Wellona Pharma Recent Development Table 162. SAVAL Pharma Company Information Table 163. SAVAL Pharma Business Overview Table 164. SAVAL Pharma Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. SAVAL Pharma Anti-vertigo Drugs Product Portfolio Table 166. SAVAL Pharma Recent Development Table 167. Santa Cruz Biotechnology, Inc Company Information Table 168. Santa Cruz Biotechnology, Inc Business Overview Table 169. Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Product Portfolio Table 171. Santa Cruz Biotechnology, Inc Recent Development Table 172. Kent Pharmaceuticals Ltd Company Information Table 173. Kent Pharmaceuticals Ltd Business Overview Table 174. Kent Pharmaceuticals Ltd Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Kent Pharmaceuticals Ltd Anti-vertigo Drugs Product Portfolio Table 176. Kent Pharmaceuticals Ltd Recent Development Table 177. Kabir Lifesciences Company Information Table 178. Kabir Lifesciences Business Overview Table 179. Kabir Lifesciences Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Kabir Lifesciences Anti-vertigo Drugs Product Portfolio Table 181. Kabir Lifesciences Recent Development Table 182. AdvaCare Pharma Company Information Table 183. AdvaCare Pharma Business Overview Table 184. AdvaCare Pharma Anti-vertigo Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. AdvaCare Pharma Anti-vertigo Drugs Product Portfolio Table 186. AdvaCare Pharma Recent Development Table 187. North America Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. North America Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 189. North America Anti-vertigo Drugs Sales Market Share by Country (2021-2026) Table 190. North America Anti-vertigo Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 191. North America Anti-vertigo Drugs Sales Market Share Forecast by Country (2027-2032) Table 192. North America Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. North America Anti-vertigo Drugs Market Size by Country (2021-2026) & (US$ Million) Table 194. North America Anti-vertigo Drugs Market Share by Country (2021-2026) Table 195. North America Anti-vertigo Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. North America Anti-vertigo Drugs Market Share Forecast by Country (2027-2032) Table 197. Europe Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Europe Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 199. Europe Anti-vertigo Drugs Sales Market Share by Country (2021-2026) Table 200. Europe Anti-vertigo Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 201. Europe Anti-vertigo Drugs Sales Market Share Forecast by Country (2027-2032) Table 202. Europe Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Europe Anti-vertigo Drugs Market Size by Country (2021-2026) & (US$ Million) Table 204. Europe Anti-vertigo Drugs Market Share by Country (2021-2026) Table 205. Europe Anti-vertigo Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Europe Anti-vertigo Drugs Market Share Forecast by Country (2027-2032) Table 207. Asia-Pacific Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 208. Asia-Pacific Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 209. Asia-Pacific Anti-vertigo Drugs Sales Market Share by Country (2021-2026) Table 210. Asia-Pacific Anti-vertigo Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 211. Asia-Pacific Anti-vertigo Drugs Sales Market Share Forecast by Country (2027-2032) Table 212. Asia-Pacific Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 213. Asia-Pacific Anti-vertigo Drugs Market Size by Country (2021-2026) & (US$ Million) Table 214. Asia-Pacific Anti-vertigo Drugs Market Share by Country (2021-2026) Table 215. Asia-Pacific Anti-vertigo Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 216. Asia-Pacific Anti-vertigo Drugs Market Share Forecast by Country (2027-2032) Table 217. Latin America Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 218. Latin America Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 219. Latin America Anti-vertigo Drugs Sales Market Share by Country (2021-2026) Table 220. Latin America Anti-vertigo Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 221. Latin America Anti-vertigo Drugs Sales Market Share Forecast by Country (2027-2032) Table 222. Latin America Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 223. Latin America Anti-vertigo Drugs Market Size by Country (2021-2026) & (US$ Million) Table 224. Latin America Anti-vertigo Drugs Market Share by Country (2021-2026) Table 225. Latin America Anti-vertigo Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 226. Latin America Anti-vertigo Drugs Market Share Forecast by Country (2027-2032) Table 227. Middle East and Africa Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 228. Middle East and Africa Anti-vertigo Drugs Sales by Country (2021-2026) & (K Units) Table 229. Middle East and Africa Anti-vertigo Drugs Sales Market Share by Country (2021-2026) Table 230. Middle East and Africa Anti-vertigo Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 231. Middle East and Africa Anti-vertigo Drugs Sales Market Share Forecast by Country (2027-2032) Table 232. Middle East and Africa Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 233. Middle East and Africa Anti-vertigo Drugs Market Size by Country (2021-2026) & (US$ Million) Table 234. Middle East and Africa Anti-vertigo Drugs Market Share by Country (2021-2026) Table 235. Middle East and Africa Anti-vertigo Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 236. Middle East and Africa Anti-vertigo Drugs Market Share Forecast by Country (2027-2032) Table 237. Key Raw Materials Table 238. Raw Materials Key Suppliers Table 239. Anti-vertigo Drugs Distributors List Table 240. Anti-vertigo Drugs Customers List Table 241. Research Programs/Design for This Report Table 242. Authors List of This Report Table 243. Secondary Sources Table 244. Primary Sources List of Figures Figure 1. Anti-vertigo Drugs Image Figure 2. Global Anti-vertigo Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-vertigo Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-vertigo Drugs Sales (2021-2032) & (K Units) Figure 5. Betahistine Image Figure 6. Global Betahistine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Diphenidol Image Figure 8. Global Diphenidol Sales YoY Growth (2021-2032) & (K Units) Figure 9. Flunarizine Image Figure 10. Global Flunarizine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Anti-vertigo Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Anti-vertigo Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Anti-vertigo Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Anti-vertigo Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Anti-vertigo Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Anti-vertigo Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Anti-vertigo Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Anti-vertigo Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Anti-vertigo Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Anti-vertigo Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Anti-vertigo Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Anti-vertigo Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Anti-vertigo Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Anti-vertigo Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Anti-vertigo Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Anti-vertigo Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Anti-vertigo Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Anti-vertigo Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Anti-vertigo Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Anti-vertigo Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Anti-vertigo Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Anti-vertigo Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Anti-vertigo Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Anti-vertigo Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Anti-vertigo Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Anti-vertigo Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Anti-vertigo Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Anti-vertigo Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anti-vertigo Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Anti-vertigo Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Anti-vertigo Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anti-vertigo Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Anti-vertigo Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Anti-vertigo Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anti-vertigo Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Anti-vertigo Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Anti-vertigo Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anti-vertigo Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Anti-vertigo Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-vertigo Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Anti-vertigo Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Anti-vertigo Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Anti-vertigo Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Betahistine
  • Diphenidol
  • Flunarizine
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Zhejiang Proconyu Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Weifang Zhongshi Pharmaceutical Co., Ltd.
  • Tianfang Pharmaceutical Co., Ltd.
  • Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Shandong Xinyi Pharmaceutical Co., Ltd.
  • Renhetang Pharmaceutical Co., Ltd.
  • Jiangsu Sihuan Biopharmaceutical Co., Ltd.
  • Jinan Yongning Pharmaceutical Co., Ltd.
  • China Resources Shuanghe Pharmaceutical Co., Ltd.
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  • Heilongjiang Yidahong Pharmaceutical Co., Ltd.
  • Henan Zhongjie Pharmaceutical Co., Ltd.
  • Guangdong Lingnan Pharmaceutical Co., Ltd.
  • Guangdong Bangmin Pharmaceutical Co., Ltd.
  • Beijing Juneng Pharmaceutical Co., Ltd.
  • Wellona Pharma
  • SAVAL Pharma
  • Santa Cruz Biotechnology, Inc
  • Kent Pharmaceuticals Ltd
  • Kabir Lifesciences
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-vertigo Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-vertigo Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-vertigo Drugs Market by Type
  6. 1.3.1 Betahistine
  7. 1.3.2 Diphenidol
  8. 1.3.3 Flunarizine
  9. 1.4 Global Anti-vertigo Drugs Market Size by Type
  10. 1.4.1 Global Anti-vertigo Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Anti-vertigo Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Anti-vertigo Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Anti-vertigo Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Anti-vertigo Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Anti-vertigo Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Anti-vertigo Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Anti-vertigo Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-vertigo Drugs Industry Trends
  2. 2.2 Anti-vertigo Drugs Industry Drivers
  3. 2.3 Anti-vertigo Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-vertigo Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-vertigo Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-vertigo Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-vertigo Drugs Price (2021-2026)
  4. 3.4 Global Anti-vertigo Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-vertigo Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-vertigo Drugs Company, Product Type & Application
  7. 3.7 Global Anti-vertigo Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-vertigo Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-vertigo Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-vertigo Drugs Tier 1, Tier 2, and Tier 3
4 Anti-vertigo Drugs Regional Status and Outlook
  1. 4.1 Global Anti-vertigo Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-vertigo Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-vertigo Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-vertigo Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-vertigo Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-vertigo Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-vertigo Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-vertigo Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-vertigo Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-vertigo Drugs by Application
  1. 5.1 Anti-vertigo Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Other
  6. 5.2 Global Anti-vertigo Drugs Market Size by Application
  7. 5.2.1 Global Anti-vertigo Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-vertigo Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-vertigo Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-vertigo Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-vertigo Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-vertigo Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-vertigo Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-vertigo Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Proconyu Pharmaceutical Co., Ltd.
  2. 6.1.1 Zhejiang Proconyu Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Zhejiang Proconyu Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Proconyu Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  6. 6.1.5 Zhejiang Proconyu Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Southwest Pharmaceutical Co., Ltd.
  8. 6.2.1 Southwest Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Southwest Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  12. 6.2.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Weifang Zhongshi Pharmaceutical Co., Ltd.
  14. 6.3.1 Weifang Zhongshi Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Weifang Zhongshi Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Weifang Zhongshi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  18. 6.3.5 Weifang Zhongshi Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Tianfang Pharmaceutical Co., Ltd.
  20. 6.4.1 Tianfang Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Tianfang Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tianfang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  24. 6.4.5 Tianfang Pharmaceutical Co., Ltd. Recent Developments
  25. 6.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
  26. 6.5.1 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  30. 6.5.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  32. 6.6.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  36. 6.6.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shandong Xinyi Pharmaceutical Co., Ltd.
  38. 6.7.1 Shandong Xinyi Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shandong Xinyi Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shandong Xinyi Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  42. 6.7.5 Shandong Xinyi Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Renhetang Pharmaceutical Co., Ltd.
  44. 6.8.1 Renhetang Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Renhetang Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Renhetang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  48. 6.8.5 Renhetang Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Jiangsu Sihuan Biopharmaceutical Co., Ltd.
  50. 6.9.1 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  54. 6.9.5 Jiangsu Sihuan Biopharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Jinan Yongning Pharmaceutical Co., Ltd.
  56. 6.10.1 Jinan Yongning Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Jinan Yongning Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jinan Yongning Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  60. 6.10.5 Jinan Yongning Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 China Resources Shuanghe Pharmaceutical Co., Ltd.
  62. 6.11.1 China Resources Shuanghe Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 China Resources Shuanghe Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 China Resources Shuanghe Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  66. 6.11.5 China Resources Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
  68. 6.12.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  72. 6.12.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Heilongjiang Yidahong Pharmaceutical Co., Ltd.
  74. 6.13.1 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  78. 6.13.5 Heilongjiang Yidahong Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Henan Zhongjie Pharmaceutical Co., Ltd.
  80. 6.14.1 Henan Zhongjie Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Henan Zhongjie Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Henan Zhongjie Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  84. 6.14.5 Henan Zhongjie Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Guangdong Lingnan Pharmaceutical Co., Ltd.
  86. 6.15.1 Guangdong Lingnan Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Guangdong Lingnan Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Guangdong Lingnan Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  90. 6.15.5 Guangdong Lingnan Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Guangdong Bangmin Pharmaceutical Co., Ltd.
  92. 6.16.1 Guangdong Bangmin Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Guangdong Bangmin Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Guangdong Bangmin Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  96. 6.16.5 Guangdong Bangmin Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Beijing Juneng Pharmaceutical Co., Ltd.
  98. 6.17.1 Beijing Juneng Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Beijing Juneng Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Juneng Pharmaceutical Co., Ltd. Anti-vertigo Drugs Product Portfolio
  102. 6.17.5 Beijing Juneng Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Wellona Pharma
  104. 6.18.1 Wellona Pharma Company Information
  105. 6.18.2 Wellona Pharma Business Overview
  106. 6.18.3 Wellona Pharma Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Wellona Pharma Anti-vertigo Drugs Product Portfolio
  108. 6.18.5 Wellona Pharma Recent Developments
  109. 6.19 SAVAL Pharma
  110. 6.19.1 SAVAL Pharma Company Information
  111. 6.19.2 SAVAL Pharma Business Overview
  112. 6.19.3 SAVAL Pharma Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 SAVAL Pharma Anti-vertigo Drugs Product Portfolio
  114. 6.19.5 SAVAL Pharma Recent Developments
  115. 6.20 Santa Cruz Biotechnology, Inc
  116. 6.20.1 Santa Cruz Biotechnology, Inc Company Information
  117. 6.20.2 Santa Cruz Biotechnology, Inc Business Overview
  118. 6.20.3 Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Santa Cruz Biotechnology, Inc Anti-vertigo Drugs Product Portfolio
  120. 6.20.5 Santa Cruz Biotechnology, Inc Recent Developments
  121. 6.21 Kent Pharmaceuticals Ltd
  122. 6.21.1 Kent Pharmaceuticals Ltd Company Information
  123. 6.21.2 Kent Pharmaceuticals Ltd Business Overview
  124. 6.21.3 Kent Pharmaceuticals Ltd Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Kent Pharmaceuticals Ltd Anti-vertigo Drugs Product Portfolio
  126. 6.21.5 Kent Pharmaceuticals Ltd Recent Developments
  127. 6.22 Kabir Lifesciences
  128. 6.22.1 Kabir Lifesciences Company Information
  129. 6.22.2 Kabir Lifesciences Business Overview
  130. 6.22.3 Kabir Lifesciences Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Kabir Lifesciences Anti-vertigo Drugs Product Portfolio
  132. 6.22.5 Kabir Lifesciences Recent Developments
  133. 6.23 AdvaCare Pharma
  134. 6.23.1 AdvaCare Pharma Company Information
  135. 6.23.2 AdvaCare Pharma Business Overview
  136. 6.23.3 AdvaCare Pharma Anti-vertigo Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 AdvaCare Pharma Anti-vertigo Drugs Product Portfolio
  138. 6.23.5 AdvaCare Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Anti-vertigo Drugs Sales by Country
  2. 7.1.1 North America Anti-vertigo Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-vertigo Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-vertigo Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-vertigo Drugs Market Size by Country
  6. 7.2.1 North America Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-vertigo Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-vertigo Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-vertigo Drugs Sales by Country
  2. 8.1.1 Europe Anti-vertigo Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-vertigo Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-vertigo Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-vertigo Drugs Market Size by Country
  6. 8.2.1 Europe Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-vertigo Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-vertigo Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-vertigo Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-vertigo Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-vertigo Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-vertigo Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-vertigo Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-vertigo Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-vertigo Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-vertigo Drugs Sales by Country
  2. 10.1.1 South America Anti-vertigo Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-vertigo Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-vertigo Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-vertigo Drugs Market Size by Country
  6. 10.2.1 South America Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-vertigo Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-vertigo Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-vertigo Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-vertigo Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-vertigo Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-vertigo Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-vertigo Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-vertigo Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-vertigo Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-vertigo Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-vertigo Drugs Value Chain Analysis
  2. 12.1.1 Anti-vertigo Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-vertigo Drugs Production Mode & Process
  7. 12.2 Anti-vertigo Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-vertigo Drugs Distributors
  10. 12.2.3 Anti-vertigo Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst